![Michael Castagna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Castagna
Vorstandsvorsitzender bei
MANNKIND CORPORATION
Vermögen: 9 Mio $ am 31.05.2026
Profil
Michael E.
Castagna is Chief Executive Officer & Director at MannKind Corp.
since 2017, President, Chief Executive Officer & Director at scPharmaceuticals, Inc. starting in 2025, and Director at Pet Partners.
Former roles include Executive Director-Immunology Franchise at Bristol Myers Squibb Co. from 2010 to 2012, Director at Pharmasset, Inc. from 2005 to 2006, Vice President-Global Commercial at Amgen, Inc. from 2012 to 2016, Vice President & Head-Biopharmaceuticals at Sandoz, Inc. from 2009 to 2010, and VP & Head-North America Biopharmaceuticals at Novartis AG.
Education includes a doctorate from Massachusetts College of Pharmacy & Health Science in 2014, an MBA from The Wharton School of the University of Pennsylvania in 2005, and an undergraduate degree from Philadelphia College of Pharmacy in 2000.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MANNKIND CORPORATION 0.79% | 11.05.2026 | 2’442’310 ( 0.79% ) | 9 Mio $ | 31.05.2026 |
Aktive Positionen von Michael Castagna
| Unternehmen | Position | Beginn |
|---|---|---|
| MANNKIND CORPORATION | Vorstandsvorsitzender | 25.05.2017 |
| SCPHARMACEUTICALS INC. | Vorstandsvorsitzender | 07.10.2025 |
Pet Partners
 Pet Partners Agricultural Commodities/MillingProcess Industries Provides pet therapy services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Castagna
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 14.03.2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.11.2012 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Corporate Officer/Principal | 01.11.2010 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Direktor/Vorstandsmitglied | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Ausbildung von Michael Castagna
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
MannKind Corp.
 MannKind Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes therapeutic products | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Massachusetts College of Pharmacy & Health Science
 Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Philadelphia College of Pharmacy
 Philadelphia College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pet Partners
Pet Partners Agricultural Commodities/MillingProcess Industries Provides pet therapy services | Process Industries |
Wählen Sie MarketScreener 
